Taking up the slack from HRT

Related tags Hrt Estrogen Medicine

More than half the women participating in a trial in New Zealand
stopped taking HRT after last year's Women's Health study, report
researchers this week. Are natural supplements filling the gap?

More than half the women participating in a trial in New Zealand stopped taking HRT after a study last year linked the treatment to significant side effects, report researchers this week.

The study did not reveal if the women had found alternative treatments for menopause symptoms but the results suggest that large numbers of women could be seeking new options to help symptoms. The natural products industry has seen strong growth in soy isoflavones and other natural treatments in recent months, with Dutch firm Acatris reporting recently that its clients had more than tripled sales since last year.

The study began six months after the Women's Health Initiative results were published, surveying 776 women who were taking HRT.

Of 734 respondents, 423 (58 per cent) had stopped taking HRT when the results were published, 132 (18 per cent) had restarted at the time of the survey, and 291 (40 per cent) had not, write researchers in today's issue of the British Medical Journal​.

Of the 132 women who restarted, 100 did so because of the return of symptoms, 16 because they 'felt better' on HRT, and 15 for other reasons.

Most respondents (83 per cent) reported that they had discussed HRT with a health professional. The authors also found that older age, use of combined HRT, and longer duration of HRT were associated with stopping HRT.

The researchers from the Wellington School of Medicine and Health Sciences said the data suggest that stopping HRT was consistent with updated international guidelines.

The 2002 Women's Health Initiative report showed that combined oestrogen plus progestogen increased rates of breast cancer, coronary heart disease, stroke, and venous thromboembolism in healthy postmenopausal women. They found decreased rates of hip fracture and colorectal disease but no 'global' benefit and concluded that combined oestrogen and progestogen was not suitable for the prevention of chronic diseases (JAMA 2002;288: 321-33).

Related topics Proteins

Related news

Show more

Related products

show more

Future Food-Tech London - Download Summit Brochure

Future Food-Tech London - Download Summit Brochure

Content provided by Future Food-Tech London, September 28-29, 2023 | 01-Aug-2023 | Product Brochure

Future Food-Tech's European flagship brings together 800+ leaders from food brands, ingredient providers, pioneering entrepreneurs, and investors,...

From Pod to Plate: Unlock the Power of Pea Protein

From Pod to Plate: Unlock the Power of Pea Protein

Content provided by ADM | 12-Jul-2023 | Case Study

ADM is expanding our world-class textured pea protein portfolio with our newest solutions, AccelFlex™ TS P80 and AccelFlex™ TS P65. Both feature a clean,...

The latest trends in plant-based meat alternatives

The latest trends in plant-based meat alternatives

Content provided by ADM | 10-Jul-2023 | Infographic

Today’s consumers are increasingly taking a proactive approach to their health and wellness, seeking expanded protein choices to diversify their diets....

Related suppliers

Follow us

Products

View more

Webinars